Kutatási jelek – Signal Engine

• Avelumab in patients with chemotherapy‑refractory metastatic Merkel cell carcinoma: a multicentre, single‑group, open‑label, phase 2 trial — Merkel cell carcinoma
• Advancements in Immunotherapy for Anal Cancer Treatment — Anal squamous cell carcinoma
• Gastric cancer — Gastric cancer
• The concept of treatment‑free remission in chronic myeloid leukemia — Lymphoma
• Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer — Ovarian cancer
• Diagnostic accuracy of multi‑parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study — Prostate cancer
• Acute myeloid leukemia: advancing clinical trials and promising therapeutics — Leukemia
• Non‑small cell lung cancer: current treatment and future advances — NSCLC
• Small cell lung cancer (SCLC): no treatment advances in recent years — SCLC
• Esophageal Cancer Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf — Esophageal cancer
• Alecensa Gains FDA Approval for ALK-Positive Lung Cancer — NSCLC
• Advances in emerging drugs for osteosarcoma — Osteosarcoma
• Prospective Analysis: Relative Survival in Patients with Chronic Myeloid Leukemia in Chronic Phase in the Era of Tyrosine Kinase Inhibitors — Chronic myeloid leukemia
• Potential proteins identified to target in osteosarcoma treatment — Osteosarcoma
• Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise — Cholangiocarcinoma
• Phase II Trial of Bevacizumab in Combination With Temozolomide as First-Line Treatment in Patients With Metastatic Uveal Melanoma — Uveal melanoma
• Systemic Therapy for Osteosarcoma and Ewing Sarcoma — Osteosarcoma
• The Cervix Cancer Research Network: Increasing Access to Cancer Clinical Trials in Low- and Middle-Income Countries — Cervical cancer
• Treatment of Small‑Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American College of Chest Physicians Guideline — SCLC
• Trial Design and Objectives for Castration‑Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group — Prostate cancer